Patents by Inventor MAHUA CHOUDHURY

MAHUA CHOUDHURY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of predicting preeclampsia using biomarkers
    Patent number: 11344121
    Abstract: The subject invention pertains to biomarkers for identifying a subject as having high risk of the development PE. The biomarkers presented herein include miRNAs, post-translational modification of histone proteins, amount, expression and/or activity of histone or DNA modifying enzymes and methylation of sites in the genomic DNA. In certain embodiments, increased miR-17, increased acetylation of H4 histone protein, decreased amount, expression and/or activity of HDACS mRNA or protein or increased methylation of DNA at the genomic site CYP19A1 in the blood, serum or plasma of a subject compared to that of a control subject is used to predict the development of PE in the subject. The invention also provides kits and reagents to conduct assays to quantify biomarkers described herein. The invention further provides the methods of treating and/or managing PE in a subject identified as having a high risk of the development of PE.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: May 31, 2022
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventor: Mahua Choudhury
  • Hydrogel condom
    Patent number: 11291750
    Abstract: A hydrogel condom containing an antioxidant can provide increased sexual pleasure, thus improving usage and resulting in prevention of disease and prevention of unwanted pregnancies.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: April 5, 2022
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Mahua Choudhury, Xiaofeng Kang, Allison R. Ficht
  • HYDROGEL CONDOM
    Publication number: 20190060530
    Abstract: A hydrogel condom containing an antioxidant can provide increased sexual pleasure, thus improving usage and resulting in prevention of disease and prevention of unwanted pregnancies.
    Type: Application
    Filed: February 23, 2017
    Publication date: February 28, 2019
    Applicant: The Texas A&M University System
    Inventors: Mahua CHOUDHURY, Xiaofeng KANG
  • FIRST TRIMESTER EPIGENETIC AND MICRORNA BIOMARKERS FOR PREECLAMPSIA
    Publication number: 20190055605
    Abstract: The subject invention pertains to biomarkers for identifying a subject as having high risk of the development PE. The biomarkers presented herein include miRNAs, post-translational modification of histone proteins, amount, expression and/or activity of histone or DNA modifying enzymes and methylation of sites in the genomic DNA. In certain embodiments, increased miR-17, increased acetylation of H4 histone protein, decreased amount, expression and/or activity of HDAC5 mRNA or protein or increased methylation of DNA at the genomic site CYP19A1 in the blood, serum or plasma of a subject compared to that of a control subject is used to predict the development of PE in the subject. The invention also provides kits and reagents to conduct assays to quantify biomarkers described herein. The invention further provides the methods of treating and/or managing PE in a subject identified as having a high risk of the development of PE.
    Type: Application
    Filed: April 14, 2017
    Publication date: February 21, 2019
    Inventor: MAHUA CHOUDHURY